Money, Mistrust, and Machines: What’s Shaping the Future of Vet Med
In the latest episode of Vet Candy Watch, Career Coach Vet Dr. Ashley Hopkins takes a closer look at the biggest conversations shaping the veterinary profession today. From economic realities to public perception and global innovation, this episode explores the issues that every veterinary professional should be paying attention to.
Dr. Hayley McDonald, Veterinary Cardiologist, Explains all about Felicyn CA-1
Felycin®-CA1 is the first and only FDA conditionally approved once-weekly drug for the management of ventricular hypertrophy in cats with subclinical HCM. Watch Dr. Hayley McDonald, California based veterinary cardiologist, to learn more about Felycin-CA1
Veterinary cardiologist, Dr. Hayley McDonald Explains All about Felicyn CA-1
Felycin®-CA1 (sirolimus delayed-release tablets) is the first disease-modifying drug that can give hope to owners of cats with subclinical hypertrophic cardiomyopathy (HCM).Felycin®-CA1 is the first and only FDA conditionally approved once-weekly drug for the management of ventricular hypertrophy in cats with subclinical HCM.
From New Zealand Barns to California ORs: The Trailblazing Vet Redefining Heart Care for Pets
Discover how Dr. Hayley McDonald went from a small-town Kiwi vet to a California-based veterinary cardiology pioneer—through determination, innovation, and a love for adventure.